30th Apr 2013 16:00
SHIRE PLC - Results of the 2013 Annual General MeetingSHIRE PLC - Results of the 2013 Annual General Meeting
PR Newswire
London, April 30
Results of the 2013 Annual General Meeting
April 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announcesthat at its Annual General Meeting held at The Merrion Hotel, Upper MerrionStreet, Dublin 2, Ireland at 1.30 pm today, all resolutions contained in thenotice of meeting were decided by poll vote. The results of the poll are asfollows: Resolution For (includ % Against % Votes Withheld ing cast as discretionary a % of votes) relevant shares in issue Ordinary Resolutions1. To receive the 382,529,501 98.84% 4,489,634 1.16% 69.67% 471,342Company's accounts and
the reports of theDirectors and Auditor 2. To approve the 361,222,372 96.26% 14,042,536 3.74% 67.56% 12,225,569Directors'remuneration report3. To re-elect William 386,014,484 99.74% 993,719 0.26% 69.67% 482,274Burns as a Director
4. To re-elect Matthew 355,714,543 94.13% 22,201,249 5.87% 68.03% 9,574,685Emmens as a Director
5. To re-elect Dr. 386,808,763 99.95% 195,914 0.05% 69.67% 485,800David Ginsburg as a
Director6. To re-elect Graham 386,293,509 99.82% 714,353 0.18% 69.67% 482,615Hetherington as a
Director7. To re-elect David 385,216,321 99.66% 1,308,525 0.34% 69.58% 965,631Kappler as a Director
8. To re-elect Susan 386,814,545 99.95% 194,529 0.05% 69.67% 481,403Kilsby as a Director
9. To re-elect Anne 386,527,128 99.88% 480,970 0.12% 69.67% 482,379Minto as a Director
10. To re-elect David 386,808,105 99.95% 196,042 0.05% 69.67% 486,330Stout as a Director
11. To elect Dr. 386,816,503 99.95% 188,864 0.05% 69.67% 485,110Steven Gillis as a
Director12. To elect Dr. 386,823,276 99.95% 183,782 0.05% 69.67% 483,419Flemming Ornskov as a
Director13. To re-appoint 385,655,383 99.65% 1,364,730 0.35% 69.67% 470,364Deloitte LLP as the
Company's Auditor 14. To authorize the 386,676,440 99.92% 317,206 0.08% 69.67% 496,831Audit, Compliance &Risk Committee todetermine theremuneration of theAuditor15. To authorize the 367,007,043 95.25% 18,316,951 4.75% 69.37% 2,166,483allotment of shares
Special Resolutions 16. To authorize the 383,547,612 99.76% 913,946 0.24% 69.21% 3,028,919disapplication ofpre-emption rights 17. To authorize 384,709,895 99.42% 2,250,776 0.58% 69.66% 529,806market purchases 18. To approve the 326,322,921 84.33% 60,650,077 15.67% 69.66% 517,479notice period forgeneral meetingsAs at the record date, April 28, 2013, there were 555,680,549 ordinary sharesin issue (excluding shares held in treasury). Shareholders are entitled to onevote per share. A vote "withheld" is not a vote in law and is not counted inthe calculation of the proportion of votes validly cast.
In accordance with Listing Rule 9.6.2R copies of the relevant resolutionspassed at the meeting have been submitted to the National Storage Mechanism andwill be available for viewing shortly at: www.morningstar.co.uk/uk/nsm and alsovia the Company's website at www.shire.com.
Tony GuthrieDeputy Company SecretaryFor further information please contact:
Investor Relations Eric Rojas ([email protected]) +1 781 482 0999 Sarah Elton-Farr ([email protected]) +44 1256 894157 NOTES TO EDITORSShire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients' needs, we develop and providehealthcare in the areas of:
* Behavioral Health and Gastro Intestinal conditions * Rare Diseases * Regenerative Medicineas well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value forpatients, physicians, policymakers, payors and our shareholders.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
Press Releasewww.shire.com
Related Shares:
Shire